# FDA Inspection 1228634 - Novartis Gene Therapies Inc. - January 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/novartis-gene-therapies-inc/ab2c39ea-5177-471e-8597-985d34d47929
Source feed: FDA_Inspections

> FDA Inspection 1228634 for Novartis Gene Therapies Inc. on January 26, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228634
- Company Name: Novartis Gene Therapies Inc.
- Inspection Date: 2024-01-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/novartis-gene-therapies-inc/23cc49c0-8794-437d-a2c2-4197479c5fb3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d